ALLMedicine™ Potassium Center

Feb 23rd, 2021 - Introduction: Patients with cardiovascular diseases (CVD) are at increased risk of hyperkalemia, particularly when treated with renin-angiotensin-aldosterone inhibitors (RAASIs). Because the occurrence or fear of hyperkalemia, RAASIs are frequentl...

Feb 23rd, 2021 - Many bacteria use cyclic di-AMP as a second messenger to control potassium and osmotic homeostasis. In Bacillus subtilis, several c-di-AMP binding proteins and RNA molecules have been identified. Most of these targets play a role in controlling po...

Feb 22nd, 2021 - The cannabinoid CB1 receptor (CB1R) has been shown in preclinical studies to be involved in nicotine reinforcement and relapse-like behavior. The common single nucleotide polymorphism (SNP) rs2023239 may code for an alternative CB1R protein, alter...

Feb 21st, 2021 - Short-term mortality risk of different plasma potassium levels in patients treated with combination antihypertensive therapy.|2021|Krogager ML,Torp-Pedersen C,|

Feb 21st, 2021 - Ischaemic heart disease is classically associated with coronary artery disease. Recent evidences showed the correlation between coronary microvascular dysfunction and ischaemic heart disease, even independently of coronary artery disease. Ion chan...

Oct 7th, 2019 - The AMBER trial showed that the potassium binder patiromer was effective at allowing more patients to remain on spironolactone.

Sep 30th, 2019 - Herbs have a long history of use as folk medicine anticonvulsants, yet the underlying mechanisms often remain unknown. Neuronal voltage-gated potassium channel subfamily Q (KCNQ) dysfunction can cause severe epileptic encephalopathies that are res...

Nov 6th, 2017 - This document serves to summarize the issues and the American Thyroid Association (ATA) position regarding the use of potassium iodide as a thyroid blocking agent in the event of a nuclear accident. The purpose is to provide a review and updated p.

May 25th, 2017 - This document serves to summarize the issues and the American Thyroid Association (ATA) position regarding the use of potassium iodide as a thyroid blocking agent in the event of a nuclear accident. The purpose is to provide a review and updated p...

Jun 21st, 2016 - The conservative management of chronic kidney disease (CKD) includes nutritional therapy (NT) with the aim to reduce the intake of proteins, phosphorus, organic acids, sodium, and potassium, while ensuring adequate caloric intake. While there is e...

Feb 23rd, 2021 - Introduction: Patients with cardiovascular diseases (CVD) are at increased risk of hyperkalemia, particularly when treated with renin-angiotensin-aldosterone inhibitors (RAASIs). Because the occurrence or fear of hyperkalemia, RAASIs are frequentl...

Feb 23rd, 2021 - Many bacteria use cyclic di-AMP as a second messenger to control potassium and osmotic homeostasis. In Bacillus subtilis, several c-di-AMP binding proteins and RNA molecules have been identified. Most of these targets play a role in controlling po...

Feb 22nd, 2021 - The cannabinoid CB1 receptor (CB1R) has been shown in preclinical studies to be involved in nicotine reinforcement and relapse-like behavior. The common single nucleotide polymorphism (SNP) rs2023239 may code for an alternative CB1R protein, alter...

Feb 22nd, 2021 - Uses builds increasing protection against painful sensitivity of the teeth to cold, heat, acids, sweets or contact aids in the prevention of dental cavitiesPurpose Antihypersensitivity Anticavity

Feb 22nd, 2021 - XYWAV is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. XYWAV is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytim...

Summary Company Announcement Date: March 01, 2019 FDA Publish Date: March 01, 2019 Product Type: Drugs Prescription Drugs Reason for Announcement: Recall Reason Description Due to The Detection of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Com...

Summary Company Announcement Date: May 03, 2019 FDA Publish Date: May 03, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to the detection of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Company Name: Vivimed Brand...

Oct 27th, 2020 - NEW YORK (Reuters Health) - A recent move to use isotonic rather than hypotonic intravenous fluids (IVFs) in acutely ill children could be boosting their risk of developing electrolyte disorders, a new trial suggests. "Commercially available isoto...

Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...

Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...